2.21
4.25%
0.09
Handel nachbörslich:
2.14
-0.07
-3.17%
Finanzdaten der Minerva Neurosciences Inc-Aktie (NERV)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
6.83%
6.682
|
7.1719 | 6.0791 | 4.52 | 5.3485 |
Depreciation and Amortization |
0.07%
0.00136
|
0.00136 | 0.00136 | 0.00136 | 0.00136 |
Operating Income/Loss |
6.83%
-6.682
|
-7.1719 | -6.0791 | -4.52 | -5.3485 |
Income/Loss From Continuing Operations Before Tax |
5.03%
-8.5688
|
-9.0225 | -7.8204 | -6.192 | -6.9704 |
Income/Loss From Continuing Operations After Tax |
5.03%
-8.5688
|
-9.0225 | -7.8204 | -6.192 | -6.9704 |
Net Income/Loss
|
5.03%
-8.5688
|
-9.0225 | -7.8204 | -6.192 | -6.9704 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,014%
7.569
|
0.3581 | 7.569 | 5.5112 | 5.3402 |
Diluted Average Shares |
2,014%
7.569
|
0.3581 | 7.569 | 5.5112 | 5.3402 |
Basic Earnings Per Share |
5.83%
-1.13
|
-1.20 | -1.03 | -1.12 | -1.31 |
Diluted Earnings Per Share |
5.83%
-1.13
|
-1.20 | -1.03 | -1.12 | -1.31 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):